Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849

Adeno-associated virus vector as a platform for gene therapy delivery

Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381

Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems

Chan, K. Y., Jang, M. J., Yoo, B. B., Greenbaum, A., Ravi, N., Wu, W.-L., Sánchez-Guardado, L., Lois, C., Mazmanian, S. K., Deverman, B. E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4593 · Cited by 1,578

Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection

Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061

In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous

Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734

In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses

Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy

Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538 · cited 1×

Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease

Moore, B., Sharma, A. M., Goulet, M., Suter, T. A. C. S., Pelletier, C., Hu, R., Schaeffer, E., & Kelleher, R. J. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.092 · Cited by 6

Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection

Wang, J.-H., Cui, M., Liu, H., Guo, P., McGowan, J., Cheng, S.-Y., Gessler, D. J., Xie, J., Punzo, C., Tai, P. W. L., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101426 · Cited by 8

Evaluation of AAV transduction efficiency via multiple delivery routes: Insights from peripheral and central nervous system analysis

Lee, N. K., Na, D. L., Kim, J., Lee, B., Kim, H., Jang, H., Lee, J., & Chang, J. W. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.026 · Cited by 6

Boosters for adeno-associated virus (AAV) vector (r)evolution

Szumska, J., & Grimm, D. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.07.005 · Cited by 7

Opportunities for Cellular Rejuvenation in Alzheimer's Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches

Rosenzweig-Lipson, S. J. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.106 · Cited by 6

Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency

Lee, H. H. C., Latzer, I. T., Bertoldi, M., Gao, G., Pearl, P. L., Şahin, M., & Rotenberg, A. (2024) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12735 · Cited by 7

Gene therapy rescues brain edema and motor function in a mouse model of megalencephalic leukoencephalopathy with subcortical cysts

González, A. B., Sánchez, Á., Rodríguez, I., del Rey, J., Lope‐Piedrafita, S., Prat, E., Nunes, V., Chillón, M., Estévez, R., & Bosch, A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.046 · Cited by 5

Reprogramming Adeno-Associated Virus Tropism Via Displayed Peptides Tiling Receptor-LigandsPreprint

Portell, A. J., Ford, K. M., Suhardjo, A., Rainaldi, J., Bublik, M. N., Sanghvi, M., Kumar, A., Wing, M. K., Palmer, N. D., Le, D. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.26.509383 · Cited by 5

Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions

Evola, V., & Parmar, M. S. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2647033 · Cited by 4

Genetic therapies for neurological diseases

Rahim, A. A., Kurian, M. A., Zhou, H., Ferguson, R., Tabrizi, S. J., Lignani, G., Aquilina, K., & Waddington, S. N. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100093 · Cited by 4

The delivery challenge of adeno-associated virus vector-based gene therapies for neurological diseases

Pak, A., Wear, D., Tahmasian, N., Min, J. Y., Premraj, D. K., Gibbs, R., Spencer, K. A., Fang, S., Zerbes, T., Krishnan, M. R., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1768545 · Cited by 3

Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier

Yao, Y., & Bei, F. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_4 · Cited by 3

Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system

Wang, Z., Zou, P., Chen, Z., Hou, J., Son, Y. L., Yamashita, D., & Kondo, T. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03007-3 · Cited by 4

Transient receptor potential vanilloid channel 2 contributes to multi-modal endoplasmic reticulum and perinuclear space dilations that can also be observed in prion-infected mice

Zhao, W., Eid, S., Sackmann, C., Williams, D., Wang, X., Ouyang, Y., Zerbes, T., & Schmitt‐Ulms, G. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02906-2 · Cited by 3

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson’s disease

Chocarro, J., Maraña, S., Espelosin, M., Rico, A. J., Ariznabarreta, G., Lorenzo-Ramos, E., Ilarduya, M. M., Hernández-Alcoceba, R., Chillón, M., Vila, M., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01289-9 · Cited by 3

Crossing the Blood-Brain Barrier with AAVs: What’s After SMA?

Chan, Y. A., & Deverman, B. E. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_21 · Cited by 3

Engineered AAVs for Non-Invasive Functional Transgene Expression in Rodent and Non-Human Primate Central and Peripheral Nervous SystemsPreprint

Chen, X., Kumar, S. R., Adams, C. D., Yang, D., Wang, T., Arokiaraj, C. M., Wolfe, D. A., Ngo, V., Campos, L., Griffiths, J. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4048384 · Cited by 3

Disease-specific interventions: The use of cell and gene therapies for Parkinson disease

Barker, R. A., & Buttery, P. C. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00003-4 · Cited by 2

Blood–brain barrier-penetrant AAV vectors for cell type-specific gene expression in the mouse brain

Hirai, H., Iwazaki, S., Hoshino, R., Maruyama, T., Aoki, R., Radhiyanti, P. T., & Konno, A. (2025) · Anatomical Science International · doi:10.1007/s12565-025-00899-2 · Cited by 2

Epilepsy Treatment through Genetic Intervention of GABAergic Interneurons: Promises and Challenges

Podgorny, O. V., Petukhova, E. O., & Belousov, V. V. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00747 · Cited by 2

Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation

Alao, E. D., Sheibani, M., Wu, J., Marriam, U., Evans, D., Kasiri, S., Verma, M., Nitschke, S., Nitschké, F., Gray, S. J., et al. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00866 · Cited by 3

The Roads We Take: Cellular Targets and Pathways Leading Biologics Across the Blood–Brain Barrier

Baghirov, H. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.946045 · Cited by 2

Directed Evolution of AAV9 for Efficient Gene Expression in Cardiomyocytes In Vitro and In Vivo

Hüttermann, L., Schröder, L. C., Shetty, P. M. V., Jonker, T., Hille, S. S., Remes, A. K., Matzen, A., Boender, A., Grimm, D., Frank, D., et al. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.126 · Cited by 2

Regulatory Elements for Gene Therapy of Epilepsy

Chesnokova, E., Bal, N. V., Alhalabi, G., & Balaban, P. M. (2025) · Cells · doi:10.3390/cells14030236 · Cited by 2

Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice

Badesso, S., Pérez-González, M., Expósito, S., Espelosin, M., Cambria, C., D’Andrea, L., Imperato, G., Moeini, P., Vales, Á., González‐Aseguinolaza, G., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202503323 · Cited by 2

Identification of AAV variants with improved transduction of human vascular endothelial cells by screening AAV capsid libraries in non-human primates

Stamataki, M., Lüschow, J., Schlumbohm, C., Alawi, M., Lunding, L. P., Fuchs, E., Trepel, M., Schwaninger, M., & Körbelin, J. (2025) · Gene Therapy · doi:10.1038/s41434-025-00563-4 · Cited by 4

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Rapti, K., Maiakovska, O., Becker, J., Szumska, J., Zayas, M., Bubeck, F., Liu, J., Gerstmann, E., Krämer, C., Wiedtke, E., et al. (2022) · Journal of Visualized Experiments · doi:10.3791/64389 · Cited by 3

A Lac Repressor-Inducible Baculovirus Expression Vector for Controlling Adeno-Associated Virus Capsid Ratios

Slack, J. M., Nguyen, C. C., & Ibe-Enwo, A. (2023) · Viruses · doi:10.3390/v16010051 · Cited by 1

In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cordPreprint

Hanlon, K. S., Cheng, M. L., de la Cruz, D., Patel, N. J., Santoscoy, M. C., Gong, Y., Ng, C., Nguyen, D. M., Nammour, J., Clark, S. W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.13.557506 · Cited by 2

Toward an all-in-one recombinant adeno-associated virus vector for functionally ablating the prion gene using CRISPR-Cas technology

Verkuyl, C. E., Belotserkovsky, A., Zerbes, T., Williams, D., Krishnan, M. R., Zhu, S., Grunnesjoe, S., Eid, S., Zhang, C., Zhao, W., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336578 · Cited by 1

Administration of a barcoded AAV capsid library to the putamen of non-human primates identifies variants with efficient retrograde transport

Dzhashiashvili, Y., McBride, J. L., Fabyanic, E. B., Huang, X., Kelly, B. M., Walton-Gibbs, G. D., Vemireddi, V., Wicks, J. R., Nayal, M., Hippen, A. A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.009 · Cited by 1

Engineering novel AAV capsids by broadly attenuated and subsequent muscle-specific tropism in mice and NHPs

Pan, Y., Zhong, Y., Chen, H., Zhang, Y., Dai, Z., Chen, J., Tan, K., Chen, X., Qiu, D., Sheng, L., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201725 · Cited by 1

Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina

Fouani, Y., Blazevic, D., Oti, M., Becker, R., Strobel, B., Schönberger, T., Stephan, M., Wichert, S., Reichel, F. F., Seitz, I. P., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201764 · Cited by 1

Recent advancements in improving cross-species applicability of bioengineered AAV capsids

Pan, H., Li, N., Qi, J., & Chai, R. (2026) · Gene Therapy · doi:10.1038/s41434-026-00628-y · Cited by 1

A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model

Zerbes, T., Verkuyl, C. E., Zhang, C., Grunnesjoe, S., Eid, S., Arshad, H., Zhao, W., Nasser, Z., O’Shea, T., Bel, A., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014124 · Cited by 3

CA-IV-directed small-molecule shuttle enables targeted brain delivery of biologics

Ding, X., Chen, X., Boehm, P., Carretero‐Cerdán, A., Jang, S., Sullivan, E. E., Arokiaraj, C. M., Ristic, F., Kavvathas, B., Campos, L., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02294-y · Cited by 1

Huntingtin lowering therapeutics

D, N. A. M., Sena‐Esteves, M., Khvorova, A., DiFiglia, M., & Brodsky, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00004-2 · Cited by 1

A blood-brain-barrier penetrant AAV gene therapy rescues neurological deficits in mucolipidosis IV micePreprint

Sangster, M., Bishop, M., Yao, Y., Feitor, J. F., Shahriar, S., Miller, M., Chekuri, A. K., Budnik, B., Bei, F., & Grishchuk, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.03.565568 · Cited by 1

Engineering novel AAV capsids by global de-targeting and subsequent muscle-specific tropism in mice and NHPsPreprint

Yue, P., Zhong, Y., Chen, H., Zhang, Y., Dai, Z., Chen, J., Tan, K., Chen, X. B., Qiu, D., Sheng, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.19.654800 · Cited by 1

rAAV-miniBEND: A targeted vector for brain endothelial cell gene delivery and cerebrovascular malformation modelingPreprint

Li, J.-L., Bi, Z., Chen, X.-J., Ming, T., Qiu, B., Li, F., Feng, Z., Ai, D., Zhang, T., Wang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658979 · Cited by 1

Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in micePreprint

Mole, A. J., Sander, C. F., Parmar, A., Williams, A. J., Azzouz, M., Hautbergue, G. M., Shaw, P. J., Ferraiuolo, L., & Mead, R. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.01.662642 · Cited by 1

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across speciesPreprint

Mich, J. K., Sunil, S., Johansen, N., Martinez, R. A., Liu, J., Gore, B. B., Mahoney, J. T., Leytze, M., Ben‐Simon, Y., Bertagnolli, D., et al. (2025) · eLife · doi:10.7554/elife.108640.1 · Cited by 1

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across speciesPreprint

Mich, J. K., Sunil, S., Johansen, N., Martinez, R. A., Liu, J., Gore, B. B., Mahoney, J. T., Leytze, M., Ben‐Simon, Y., Bertagnolli, D., et al. (2025) · eLife · doi:10.7554/elife.108640 · Cited by 1

Bibliography

(2023) · The MIT Press eBooks · doi:10.7551/mitpress/15380.003.0024

Targeting Specific Barriers

Langel, Ü. (2023) · Springer eBooks · doi:10.1007/978-3-031-38731-9_9

Preclinical Evaluation of Neuraxial Drugs for Safety

Yaksh, T. L., Boyd, R. B., & Keifer, O. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-39558-1_12

Virus-mediated neuron-specific retrograde gene delivery in spinal cord injury

Chelyshev, Y. A., & Mukhamedshina, Y. O. (2024) · Genes and Cells · doi:10.17816/gc624407

Development of an AAV Vector System for Highly Specific and Efficient Gene Expression in MicrogliaPreprint

Aoki, R., Konno, A., Hosoi, N., Kawabata, H., & Hirai, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622037

Learning from and improving upon high-throughput screens for protein fitness with Generative AI - Application to BBB-crossing AAV designPreprint

Kashyap, A., Soniya, K., Anubhooti, Kandavel, S., Avadhani, K., Kanishka, S., Sharma, M., & Chodavarapu, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.06.627153

HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease

Esandi, J., Renault, P., Capilla-López, M. D., Blanch, R., Edo, Á., Ramirez-Gómez, D., Bosch, A., Almolda, B., Saura, C. A., Giraldo, J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117815

AAV gene therapy for Cockayne syndromePreprint

Batista, A. R., Scholand, A. C., Callahan, W. S., Watson, M. K., Sion, C. M., Mola, T., O’Hara, K., King, O. D., King, R. M., & Sena‐Esteves, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.06.658349

rAAV-Mediated Gene Therapy Targeting CNS Disorders

Suárez-Amarán, L., Chatzi, C. A., Flier, I., & Samulski, R. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_2

Ultrasound-Mediated Gene Therapy in Alzheimer’s Disease Validated through In Vivo PET ImagingPreprint

Guo, Y., Foiret, J. L., Ajenjo, J., Malek, R. S., Zhang, N., Seo, J. W., Wang, J., Jan, B. L., Raie, M. N., Tumbale, S. K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.02.703398

Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization

Fouani, Y., Oti, M., Jarosch, S., Blazevic, D., Duechs, M. J., Ketterer, S., Becker, R., Abele, S., Strobel, B., Schoenberger, T., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201693

Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice

Mole, A. J., Sander, C. F., Parmar, A., Williams, A. J., Azzouz, M., Hautbergue, G. M., Shaw, P. J., Ferraiuolo, L., & Mead, R. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-38039-z · Cited by 1

Astrocytic and endothelial GLUT1 restoration improves brain glucose homeostasis in GLUT1 deficiency syndromePreprint

Tamura, S., Shimbo, H., Aruga, N., Kawaguchi, M., Okado, H., Yasuda, Y., Miyaoka, Y., Sasakura, A., Matsuo, K., Nishihara, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709430

In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation

Dong, X., Yan, W., Long, X., & Wu, M. (2026) · BioDrugs · doi:10.1007/s40259-026-00771-3

Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1R671C/− mice

Molina‐Berenguer, M., Herrero-Martínez, D., Vallbona-Garcia, A., Vila‐Julià, F., Cámara, Y., Vales, Á., González‐Aseguinolaza, G., Torres‐Torronteras, J., & Martí, R. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00426-4

Selecting Novel Retino-tropic AAV Capsids by Directed Evolution

Westhaus, A., & Lisowski, L. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5198-8_1

Whole-brain biodistribution of AAV2, AAV8, and AAV-B10 after unilateral intracerebroventricular injection

Ye, D., Kayithi, A., Yuan, J., Wang, I., Xu, T., Boisvert, M., Paquet, M.-È., & Ye, D. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201798

Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E

Badesso, S., Espelosin, M., Alonso, C., Montilla, A., Collantes, M., Cuadrado‐Tejedor, M., & García‐Osta, A. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70285

AAV-mediated gene therapy demonstrates phenotypic rescue in a mouse model of Cockayne syndrome

Batista, A. R., Scholand, A. C., Callahan, W. S., Watson, M. K., Sion, C. M., Mola, T., O'Hara, K., Wentworth, S. A., Sena-Esteves, W. S., King, O. D., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196689

Comparative analysis of microglia-targeted AAVs reveals capsid choice drives efficiency in vitro but has limited impact in vivoPreprint

Jereb, S., D’Alessandro, L. R., Morshed, N., Chen, M., Sartore, R., Han, Z., McKinney, J. E., Brauer, P. P., Harvey, J. W., Demers, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.05.739854

Gene therapies (2015–2025): determinants of translational success

Sackett, J., Jaber, S., Gangapur, P., Biernat, M., & Bao, S. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118450

Beyond Precision: A Multidimensional Framework for Selecting Genetic Medicine Platforms

Wieland, J., Jackson, P., Penrod, W., Nadauld, S., & Barrott, J. J. (2026) · Cells · doi:10.3390/cells15181647

BI-TfR1 CapX rapidly transits the blood-brain barrier for efficient, low-dose gene delivery throughout the CNSPreprint

Chan, K. Y., Lin, C.-Y., Huang, Q., Pacouret, S., Zheng, Q., Harvey, J. W., Brauer, P. P., Johnston, J., Serack, F. E., Davis, J. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.23.753669

A cross-species AAV platform for precise microglial interrogation

Yu, F., Wang, R., Di, R., Xu, K., Gao, J., Shang, H., Yuan, Z., Dai, R., Wu, W., Weng, D., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.017

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across speciesPreprint

Mich, J. K., Sunil, S., Johansen, N., Martinez, R. A., Liu, J., Gore, B. B., Mahoney, J. T., Leytze, M., Ben‐Simon, Y., Bertagnolli, D., et al. (2026) · eLife · doi:10.7554/elife.108640.2

AAV Engineering for Improving Tropism to the Central Nervous System

Ghauri, M. S., & Ou, L. (2023) · Biology · doi:10.3390/biology12020186 · Cited by 70

Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice

Drouyer, M., Merjane, J., Nazareth, D., Knight, M., Scott, S., Liao, S. H. Y., Ginn, S. L., Zhu, E., Alexander, I. E., & Lisowski, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.024 · Cited by 16

Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier

Huang, Q., Chen, A. T., Chan, K. Y., Sorensen, H., Barry, A. J., Azari, B., Zheng, Q., Beddow, T., Zhao, B., Tobey, I. G., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002112 · Cited by 85

Directed evolution of novel AAV variants using the MCMS library for enhanced CNS tropism and reduced liver targeting in mice

Song, Q., Wu, J., Zhang, Q., Wu, S. V., Luo, X., Xu, M., Xu, Y., Wang, G., Yu, H., Chen, H., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101522 · Cited by 7

Evolution and Investigation of Engineered AAV Capsids Exhibiting Enhanced Transduction of the Central Nervous System with or without Murine Strain Specificity

Kumar, S. R., Miles, T. F., Chen, X., Brown, D. A., Dobreva, T., Huang, Q., Ding, X., Luo, Y., Einarsson, P. H., Greenbaum, A., et al. (2020)